Lavigne O, Poumeaud F, Reverdy T, Huynh VT, et al. Second-line treatment strategy following CDK4/6 inhibitors for HR-positive and HER2-negative metastatic breast cancer patients: a multicentric, retrospective, observational study. Breast Cancer Res Treat 2026;215:63.
PMID: 41591534